Mi SciELO
Servicios Personalizados
Articulo
Indicadores
- Citado por SciELO
Links relacionados
- Similares en SciELO
Compartir
Revista Cubana de Medicina
versión On-line ISSN 1561-302X
Resumen
FERNANDEZ GARCIA, Sergio; RODRIGUEZ MARTINEZ, Kenia y BOFFILL CARBO, Suselys. Pleuropathy secondary to ovulation inducers. Rev cubana med [online]. 2021, vol.60, n.1 Epub 25-Feb-2021. ISSN 1561-302X.
Introduction:
Pleural effusion is called the accumulation of fluid in the pleural space above 5 and 15 mL in a hemithorax. Different etiologies are responsible for its appearance but a group of them are given by drug etiology. Ovarian hyperstimulation syndrome is a secondary complication to the use of ovulation inducer therapy. The association of treatment with ovulation inducers in the genesis of pleural effusion is little known in the medical literature.
Objective:
To review the most important clinical-pathophysiological aspects reported on pleurisy in ovarian hyperstimulation syndrome.
Methods:
A review was carried out on the purpose of a clinical case of a 34-year-old patient with a medical history, followed in a fertility consultation. She was treated with clomiphene citrate and she developed an immediate moderate ovarian hyperstimulation syndrome. The clinical expression was a moderate right pleural effusion. Pleurisy is rare. It depends on the individual genetic predisposition of the patient and the susceptibility to drugs; the incidence varies between 0.6 and 10%. Different risk factors have been described, although any woman subjected to these treatments can develop it. Treatment is symptomatic, restoring the intravascular volume with the administration of crystalloids and / or albumin.
Conclusions:
The association of ovarian hyperstimulation syndrome and pleuropathy secondary to treatment with clomiphene citrate is not frequent.
Palabras clave : pleural effusion; ovarian hyperstimulation; inducers of ovulation.